Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Pharma Elite AB
AB
Active
Org 5594601840
Svedjevägen 1
Retail sale of pharmaceutical products · NACE 4773
Est. 2023
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 436K
-20% vs 2024
EBITDA margin
5.5%
-88% vs 2024
Equity ratio
15.4%
Financial strength
Net profit 2025
SEK 8K
-94% vs 2024
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
SEK 436K
-20%
EBITDA
SEK 24K
-88%
Net profit
SEK 8K
-94%
Total assets
SEK 217K
-35%
Equity
SEK 33K
-80%
Employees
0
—
Company information
Legal name
Pharma Elite AB
Org number
5594601840
Legal form
Aktiebolag
NACE code
4773 · Retail sale of pharmaceutical products
Founded
1 december 2023
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget hjälper till med bemanning till apotek och läkemedelsindustri.
Contact
Address
Svedjevägen 1
Email
smartmiro@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Retail sale of pharmaceutical products
Companies in Skövde
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2024
0M
2025
Income statement
SEK thousands
Item
2024
2025
Revenue
544
436
Staff expenses
−327
−390
EBITDA
191
24
Depreciation & amort.
−8
−14
EBIT
183
10
Net financials
−1
1
Profit before tax
182
11
Tax
−38
−2
Net profit
145
8
Balance sheet
SEK thousands
Item
2024
2025
Total assets
333
217
Equity
170
33
Long-term debt
—
—
Short-term debt
163
164
Total debt
163
164
Financial ratios
5-year trend
EBITDA margin
5.5%
This company
15.8%
Market median
-65% vs market
2024
2025
Equity ratio
15.4%
This company
38.2%
Market median
-60% vs market
2024
2025
Return on equity
25.4%
This company
18.4%
Market median
+38% vs market
2024
2025
Net profit margin
1.9%
This company
8.1%
Market median
-77% vs market
2024
2025
Asset turnover
2.01×
This company
1.12×
Market median
+79% vs market
2024
2025
Debt / equity
5.48×
This company
0.62×
Market median
-784% vs market
2024
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-12-01 – 2024-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
AA
Ammar Al Masri
Board of Directors
2023
NA
Nour Almasri
Deputy Board Member
2023
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Pharma Elite AB also hold positions in
0
other companies.
Person
Role here
Other companies
Ammar Al Masri
Board of Directors
0 companies
Nour Almasri
Deputy Board Member
0 companies